Value in Health Regional Issues

Slides:



Advertisements
Similar presentations
Pharmacist-directed reconciliation for reducing medication discrepancies: A pilot study in a nursing home setting in Taiwan  Chun-Nan Kuo, You-Meei Lin,
Advertisements

Thyroidectomy: A novel endoscopic oral vestibular approach
Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective.
Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia  Juan-Carlos Castro, MD,
Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis  Klára Kruntorádová, MSc, Jiří Klimeš,
Thyroidectomy: A novel endoscopic oral vestibular approach
Managing Cancer Pain: Basic Principles and Invasive Treatments
Value in Health Regional Issues
Value in Health Regional Issues
The Development of the Romanian Scorecard HTA System
Medical Rehabilitation After Natural Disasters: Why, When, and How?
Comparison of three fixations for tibial plateau fractures by biomechanical study and radiographic observation  Hong-wei Chen, Guo-dong Liu, Shan Ou,
Using Dynamic Transmission Modeling to Determine Vaccination Coverage Rate Based on 5-Year Economic Burden of Infectious Disease: An Example of Pneumococcal.
Value in Health Regional Issues
Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary  András Inotai, PharmD, PhD, Zsolt Abonyi-Tóth, MSc, György.
Drug Policy in Slovakia
Musculoskeletal Comorbidities in Cardiac Patients: Prevalence, Predictors, and Health Services Utilization  Susan Marzolini, MSc, Paul I. Oh, MD, David.
Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt
From Regulatory Approval to Subsidized Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand,
Systematic Review of Economic Evaluation Literature in Ghana: Is Health Technology Assessment the Future?  Emmanuel Ankrah Odame, MBCHB, MPH  Value in.
The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan  Kaoru Yamabe, MSc, Puneet K. Singhal,
Prevalence and treatment gap of active convulsive epilepsy: A large community-based survey in rural West China  Jia Hu, Yang Si, Dong Zhou, Jie Mu, Juan.
Drug Policy in Croatia Value in Health Regional Issues
Value in Health Regional Issues
Value in Health Regional Issues
The Process of Privatization of Health Care Provision in Poland
Boxiong Tang, MD, PhD, Eran Harary, MD, Ricky Kurzman, MSc, Joaquín F
Ernest Attuquaye Quaye, BPharm, MPH, Edward O
Drug Policy in Bulgaria
Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis  Klára Kruntorádová, MSc, Jiří Klimeš,
Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system  Shan Liu, M.D.,
Value in Health Regional Issues
Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective.
Cost-Benefit Analysis and Assessment of Quality of Care in patients with Hemophilia undergoing treatment at National Rural Health Mission in Maharashtra,
Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding  Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,
Value in Health Regional Issues
Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore  Vivianne Shih, PharmD, BCOP, BCPS, Alexandre Chan, PharmD,
What Is Important During the Selection of Traditional Chinese Medicine (TCM) in a Health Care Reimbursement or Insurance System?” Critical Issues of Assessment.
Assessment of Adverse Events and Quality of Life of Cancer Patients in a Secondary Level Care, Rural Hospital in South India  S.K.R. Sowmya, PharmD, Dixon.
Jinhyun Kim, PhD, Eunhee Lee, PhD, Sungjae Kim, PhD, Tae Jin Lee, PhD 
Bernadette A. Tumanan-Mendoza, MD, MScE, MHE, Victor L. Mendoza, MD 
Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems  Randall Winnette, MSc, Victor Zárate, MD, MSc,
Advancing the Visibility, Impact, and Quality Metrics of Value in Health Regional Issues  Dan Greenberg, PhD, Imre Boncz, MD, MSc, PhD, Habil, Ahmed Awaisu,
Omneya Mohamed, PhD, David H. Kreling, PhD 
Analysis of Excess Direct Medical Costs of Vision Impairment in Taiwan
Burden of Disease Studies in the Asia-Pacific Region: Are There Enough being Performed to Provide Information for Evidence-Based Health Policy?  Fei-Li.
Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary  András Inotai, PharmD, PhD, Zsolt Abonyi-Tóth, MSc, György.
Transforming Public Servants’ Health Care Organization in Greece through the Implementation of an Electronic Referral Project  Kyriakos Souliotis, PhD,
Economic Burden of Individual Suffering from Atrial Fibrillation–Related Stroke in China  Shanlian Hu, MSc, Lin Zhan, MSc, Bao Liu, MD, PhD, Yue Gao, MD,
Drug Utilization Reviews by Community Pharmacists in Japan: Identification of Potential Safety Concerns through the Brown Bag Program  Manabu Akazawa,
Cost-Effectiveness Analysis Expands its Reach Worldwide
Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia  Juan-Carlos Castro, MD,
Pei Wang, PhD, Nan Luo, PhD, E.S. Tai, PhD, Julian Thumboo, PhD 
Guidance Document: Global Pharmacoeconomic Model Adaption Strategies
Jing Wu, PhD, Ning Yue, MS, Weiwei Xu, PhD 
Value in Health Regional Issues
Musculoskeletal Comorbidities in Cardiac Patients: Prevalence, Predictors, and Health Services Utilization  Susan Marzolini, MSc, Paul I. Oh, MD, David.
Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea  Ji Haeng Heo, MS, Karen L.
Dossier System as a Practical Tool for Compiling Reimbursement Lists
Value in Health Regional Issues
Evaluating the Long-Term Health Economic Implications of Improving the Proportion of Patients with Type 2 Diabetes Meeting Treatment Targets in Mexico 
The Drug Reimbursement Decision-Making System in Iran
Organization news Archives of Physical Medicine and Rehabilitation
Economic Evaluation of Four Drug Administration Systems in Intensive Care Units in Colombia  Diego Rosselli, MD, MSc, Juan David Rueda, MD, María Daniela.
Drug Policy in Hungary Value in Health Regional Issues
Hepatitis C Genotypes: Current Trends and Future Implications
Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables  Prabhakar Pandey, MPharm, Rishabh.
Abdol Majid Cheraghali, PhD, Peyman Eshghi, MD 
Managing Cancer Pain: Basic Principles and Invasive Treatments
Value in Health Regional Issues
Presentation transcript:

Value in Health Regional Issues Recent Pricing Negotiations on Innovative Medicines Pilot in China: Experiences, Implications, and Suggestions  Hong Li, PhD, MPH, Gordon G. Liu, PhD, Jing Wu, PhD, Jiu-Hong Wu, PhD, PharmD, Chao-Hui Dong, PhD, Shan-Lian Hu, MD, MSc  Value in Health Regional Issues  Volume 15, Pages 133-137 (May 2018) DOI: 10.1016/j.vhri.2018.01.009 Copyright © 2018 Terms and Conditions

Fig. 1 The China National Formulary (CNF). The A List contains medications that all provinces must adopt 100%, including 520 medicines on the Essential Medicine List; however, provinces can modify medications in the B List up to 15% based on local situations. CFDA, China Food and Drug Administration. Value in Health Regional Issues 2018 15, 133-137DOI: (10.1016/j.vhri.2018.01.009) Copyright © 2018 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.